These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 8239484

  • 61. AAV2-mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis.
    Griffey M, Macauley SL, Ogilvie JM, Sands MS.
    Mol Ther; 2005 Sep; 12(3):413-21. PubMed ID: 15979943
    [Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. Neuroglobin and cytoglobin: oxygen-binding proteins in retinal neurons.
    Ostojić J, Sakaguchi DS, de Lathouder Y, Hargrove MS, Trent JT, Kwon YH, Kardon RH, Kuehn MH, Betts DM, Grozdanić S.
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1016-23. PubMed ID: 16505036
    [Abstract] [Full Text] [Related]

  • 66. Abnormal excretion of autofluorescent lipids in urine from patients with neuronal ceroid lipofuscinosis.
    Ohashi T, Kanamoto Y, Yamaguchi S, Eto Y, Maekawa K.
    Tohoku J Exp Med; 1986 Apr; 148(4):335-9. PubMed ID: 3738902
    [Abstract] [Full Text] [Related]

  • 67. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis.
    Bernardini F, Warburton MJ.
    Biochem J; 2002 Sep 01; 366(Pt 2):521-9. PubMed ID: 12038963
    [Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73. Glycogenesis in the amphibian retina: in vitro conversion of [2-3H]mannose to [3H]glucose and subsequent incorporation into glycogen.
    Rodriguez IR, Fliesler SJ.
    Exp Eye Res; 1990 Jul 01; 51(1):71-7. PubMed ID: 2373183
    [Abstract] [Full Text] [Related]

  • 74. 4-Hydroxynonenal: a specific indicator for canine neuronal-retinal ceroidosis.
    Siakotos AN, Bray R, Dratz E, van Kuijk F, Sevanian A, Koppang N.
    Am J Med Genet Suppl; 1988 Jul 01; 5():171-81. PubMed ID: 3146315
    [Abstract] [Full Text] [Related]

  • 75. Principles of antioxidant therapy in neuronal ceroid lipofuscinosis.
    Westermarck T, Santavuori P.
    Med Biol; 1984 Jul 01; 62(2):148-51. PubMed ID: 6471934
    [No Abstract] [Full Text] [Related]

  • 76. Batten disease: new research findings on the biochemical defect.
    Wolfe LS, Ng Ying Kin NM.
    Birth Defects Orig Artic Ser; 1982 Jul 01; 18(6):233-9. PubMed ID: 7171758
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. [Organotypic culture of normal and neoplastic laryngeal mucosa].
    Bodo M, Pitzurra M, Sensini A, Maurizi M, Paludetti G, Fronticelli F.
    Boll Soc Ital Biol Sper; 1984 Mar 30; 60(3):611-6. PubMed ID: 6712829
    [Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80. The significance of animal models for human ceroid-lipofuscinosis.
    Koppang N.
    J Inherit Metab Dis; 1993 Mar 30; 16(2):272-3. PubMed ID: 8411978
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.